Park Ha Biological Technology Sets 1-for-50 Reverse Stock Split and Shrinks Authorized Share Capital

Park Ha Biological Technology ( (BYAH) ) just unveiled an announcement.

On February 9, 2026, Park Ha Biological Technology Co., Ltd. announced plans for a 1-for-50 reverse stock split, expected to take effect on February 20, 2026, with trading to commence on a split-adjusted basis that day, subject to Nasdaq operational requirements. The move follows shareholder approval at an extraordinary general meeting on December 26, 2025, and Board approval on January 29, 2026, signaling an effort to consolidate shares, lift the per-share trading price and adjust the capital structure.

In tandem with the reverse split, the company filed an Amended and Restated Memorandum of Association in the Cayman Islands on February 4, 2026, cutting its authorized share capital from 150 billion to 3 billion ordinary shares while increasing par value from US$0.00002 to US$0.001 per share, preserving the existing Class A and Class B voting differentials. Aligning the authorized share reduction with the same ratio as the outstanding shares suggests a deliberate tightening of the equity base, which may support compliance with listing standards and alter the dynamics of future share issuance and dilution for investors.

More about Park Ha Biological Technology

Park Ha Biological Technology Co., Ltd. is a Cayman Islands–incorporated company operating from Wuxi, Jiangsu Province, in the People’s Republic of China, and is listed on Nasdaq as a foreign private issuer. The company has a dual-class share structure, with Class A ordinary shares carrying one vote each and Class B ordinary shares carrying twenty votes each, reflecting a governance framework that concentrates voting power with key stakeholders.

Average Trading Volume: 12,344,913

Technical Sentiment Signal: Strong Sell

Current Market Cap: $2.85M

Learn more about BYAH stock on TipRanks’ Stock Analysis page.